This showed that the combined use of 5-Fu and celecoxib is able to attenuate the resistance to chemotherapy in gastric cancer and enhance the effect of chemotherapy by reducing the expression of HIF-2α, ABCG2 and Oct-4 and cancer stem cells in tumor tissue xenografts in nude mice. Here, EPAS1 is linked to cancer.